Labshake search
Citations for BioLegend :
9101 - 9150 of 10000+ citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... The following primary antibodies and dilutions were used: anti-Keratin 6A (rabbit, 1:200, Biolegend_905701), anti-Ubiquityl-Histone H2A (Lys119 ...
-
bioRxiv - Immunology 2023Quote: ... PE/Cy5 anti-mouse CD44 (103010, BioLegend, 1:100). Intracellular antibodies were ...
-
bioRxiv - Genomics 2023Quote: ... Nuclei were stained with 7-AAD Viability Staining Solution (BioLegend) and positive single nuclei were purified by fluorescent activated cell sorting (FACS ...
-
bioRxiv - Immunology 2023Quote: ... APC-Cy7 anti CD15 (W6D3;Biolegend) and PeCy5.5 anti-Flavivirus (4G2;Novus Biologicals) ...
-
bioRxiv - Immunology 2023Quote: ... BV605 anti-CD3 (OKT3;Biolegend), PE-Cy5.5 anti-CD19 (HIB19;BD) ...
-
bioRxiv - Immunology 2023Quote: ... PeCy5 anti-CD123 (6H6;Biolegend), PeCy7 anti-CD141 (M80’;Biolegend) ...
-
bioRxiv - Immunology 2023Quote: ... APC anti CD14 (M5E2;Biolegend), AF700 anti CD303 (201A;Biolegend) ...
-
bioRxiv - Immunology 2023Quote: ... BV421 anti-CD1c (L161;Biolegend), BV605 anti CD11c (3.9;Biolegend) ...
-
bioRxiv - Immunology 2023Quote: ... and APC-Cy7 anti-HLA-DR (L243;Biolegend) antibodies ...
-
bioRxiv - Immunology 2023Quote: ... AF700 anti CD303 (201A;Biolegend), APC-Cy7 anti CD15 (W6D3;Biolegend ...
-
bioRxiv - Immunology 2023Quote: ... BV605 anti CD11c (3.9;Biolegend), BV711 anti CD163 (GHI/61;Biolegend) ...
-
bioRxiv - Immunology 2023Quote: ... after staining with FITC anti-CD45 (HI30;Biolegend), BV605 anti-CD3 (OKT3;Biolegend) ...
-
bioRxiv - Immunology 2023Quote: ... PE anti-CD20 (2H7;Biolegend), and APC-Cy7 anti-HLA-DR (L243;Biolegend ...
-
bioRxiv - Immunology 2023Quote: ... BV711 anti CD163 (GHI/61;Biolegend), PeCy5 anti-CD123 (6H6;Biolegend) ...
-
bioRxiv - Bioengineering 2023Quote: ... the CNP labeled cells were spin washed and incubated with 10μgꞏml−1 of AF488 conjugated anti-CD3 antibodies (Biolegend, Cat # 300415, clone UCHT1) in 2% BSA/PBS on ice for 30min and then spin washed ...
-
bioRxiv - Bioengineering 2023Quote: ... coated glass bottom chamber and then labeled with 1ugꞏml−1 of Alexa Flour (AF) 488 conjugated anti-human CD45 antibodies (Biolegend, Cat# 304017, clone HI30) in 2% BSA in PBS for 20 min at RT ...
-
bioRxiv - Immunology 2023Quote: ... APC Cy7 anti-human HLA-DR (307618, Biolegend) and FITC anti-human CD3 (555232 ...
-
bioRxiv - Immunology 2023Quote: ... PE anti-mouse IL-17A (506904, BioLegend). Cells were acquired on a Symphony A5 (BD Biosciences ...
-
bioRxiv - Immunology 2023Quote: ... BV650 anti-mouse CD3 (100229, BioLegend, 1:100); BV711 anti-mouse CD8a (100748 ...
-
bioRxiv - Immunology 2023Quote: ... BV570 anti-mouse Ly-6C (128030, BioLegend, 1:100); BV605 anti-mouse CD80 (563052 ...
-
bioRxiv - Bioengineering 2023Quote: ... followed by staining with Brilliant Violet (BV) 785 conjugated anti-human CD69 (10 μgꞏml−1) (Biolegend, Cat # 310932, clone FN50) for 30 min on ice ...
-
bioRxiv - Cell Biology 2023Quote: ... The following primary antibodies and dilutions were used: anti-Keratin 6A (rabbit, 1:500, Biolegend_905701) 1:500 ...
-
bioRxiv - Cancer Biology 2023Quote: ... FFPE tissue sections of PDX tumours and their equivalent primary tumour region were subjected to hematoxylin and eosin (H&E) staining or immunohistochemistry using the following antibodies: anti-human CD45 (Clone: HI30; 1:200; BioLegend, #304002), anti-keratin (Clone ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-IgK (BV421; Biolegend, 392705) and anti-IgL (APC ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-IgL (APC; Biolegend, 316609). Cells were washed and re-suspended in flow cytometry buffer (PBS + 1% BSA ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-CD20 (FITC; Biolegend, 302303), anti-IgK (BV421 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Harvested cells were incubated in Dulbecco’ s Modified Eagle Medium (DMEM) with a cell activation cocktail with brefeldin A (Biolegend) for 4 hours at 37°C ...
-
bioRxiv - Cancer Biology 2023Quote: ... rat anti-CD4 (BioLegend).
-
bioRxiv - Cancer Biology 2023Quote: ... rat anti-CD8 (BioLegend), rat anti-CD4 (BioLegend).
-
bioRxiv - Bioengineering 2023Quote: ... in Annexin V binding buffer (BioLegend) according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2023Quote: ... THP-1 cells were supplemented with 100 U/ml recombinant human IFN-γ (BioLegend) for 3 days to induce PD-L1 expression ...
-
bioRxiv - Bioengineering 2023Quote: ... or 2 μM monensin (BioLegend, Cat. # 420701). After addition of DCs or T-cells to the device ...
-
bioRxiv - Bioengineering 2023Quote: ... cells were washed with FACS buffer (PBS + 2% FBS + 0.05% NaN3) and incubated with Fc receptor blocking solution (Human TruStain FcX, BioLegend) for 5 minutes ...
-
bioRxiv - Bioengineering 2023Quote: ... and AlexaFluor 647-labeled Annexin-V (AV, BioLegend) in Annexin V binding buffer (BioLegend ...
-
bioRxiv - Bioengineering 2023Quote: ... T-cells were fluorescently labeled with AlexaFluor 647 anti-human CD3 Antibody (BioLegend #300416) at a concentration of 5 μg/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... PD-L1+ cells were sorted for on a BD FACS Aria III by PD-L1 surface staining (PD-L1 PE, clone 29E.2A3, BioLegend), then expanded in vitro in T-150 flasks in cRPMI for another week in the presence of 2 μg/ml puromycin before any functional studies or EV isolations.
-
bioRxiv - Bioengineering 2023Quote: ... Cells were then stained for transferrin receptor expression by adding 0.25 μg of PE/Cy7 anti-human CD71 [CY1G4] (Biolegend, Cat# 334111) directly to the blocking solution for 30 min at room temperature ...
-
bioRxiv - Bioengineering 2023Quote: ... wherein each well mixed 50 μL of X2 photobleached conjugated magnetic beads with 50 μL solutions at different concentrations of a recombinant human Interleukin-8 (IL-8) protein (#574202, BioLegend, San Diego, CA, USA). The overall well concentration levels were 0.05 ...
-
A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis BullosabioRxiv - Bioengineering 2023Quote: ... K14 (1:800, BioLegend SIG-3476-100), and p63 (1:100 Gene Tex GTX102425) ...
-
bioRxiv - Bioengineering 2023Quote: ... and stained with Annexin V-FITC (5uL in 0.14 mL Annexin V Binding Buffer, #640914; Biolegend, San Diego, CA) for 10 minutes at 4°C in darkness ...
-
bioRxiv - Bioengineering 2023Quote: ... Propidium Iodide (#640914; Biolegend) was added (5 µL/sample ...
-
bioRxiv - Bioengineering 2023Quote: ... anti-human CD45 (BioLegend, 2D1, PE), and anti-human podoplanin (BioLegend ...
-
bioRxiv - Bioengineering 2023Quote: ... and stained with the following antibodies in FACS staining buffer (PBS with 2% Fetal Bovine Serum, 1% Penicillin-Streptomycin): anti-human CD31 (BioLegend, WM59, FITC), anti-human CD45 (BioLegend ...
-
bioRxiv - Bioengineering 2023Quote: ... The cells were then stained with anti-human IgG Fc-APC (Biolegend, Cat#366906) on ice for 30 min and washed with PBS twice ...
-
bioRxiv - Bioengineering 2023Quote: ... All reagents that were not included in the kit were purchased from BioLegend, according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2023Quote: ... and 200U/mL human IL-2 (BioLegend).
-
bioRxiv - Bioengineering 2023Quote: ... which was purchased from BioLegend. All reagents that were not included in the kit were purchased from BioLegend ...
-
bioRxiv - Bioengineering 2023Quote: ... 20ng/mL of human GM-CSF (BioLegend) was used to differentiate monocytes into macrophages for 7 days ...
-
bioRxiv - Microbiology 2023Quote: ... and F4/80-FITC (BioLegend) and fixable viability dye (BD Biosciences) ...
-
bioRxiv - Microbiology 2023Quote: ... Cells were incubated for 5 min with anti-mouse CD16/32 Ab (BioLegend) to block Fc receptors ...